@article{e274c2f39527453287df8272c217586d,
title = "Impact of infectious diseases society of America/Pediatric infectious diseases society guidelines on treatment of community-acquired pneumonia in hospitalized children",
abstract = "We examined the impact of the Pediatric Infectious Diseases Society/Infectious Diseases Society of America guidelines that recommend ampicillin or amoxicillin for children hospitalized with community-acquired pneumonia. Prescribing of ampicillin/amoxicillin increased following guideline publication, but remains low. Cephalosporin and macrolide prescribing decreased but remains common. Further studies exploring outcomes of and reasons for compliance with guidelines are warranted.",
keywords = "antibiotics, community-acquired pneumonia, guidelines, pediatrics",
author = "Ross, {Rachael K.} and Hersh, {Adam L.} and Kronman, {Matthew P.} and Newland, {Jason G.} and Metjian, {Talene A.} and Localio, {A. Russell} and Zaoutis, {Theoklis E.} and Gerber, {Jeffrey S.}",
note = "Funding Information: Potential conflicts of interest. T. E. Z. has received research funding from Merck and Cubist and has served as a consultant for Merck, Pfizer, Astellas Pharma, and Cubist. J. S. G., J. G. N., and A. L. H. have received research funding from Pfizer. All other authors report no potential conflicts.",
year = "2014",
month = mar,
doi = "10.1093/cid/ciu013",
language = "English",
volume = "58",
pages = "834--838",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
number = "6",
}